<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Kpti on Finance Insights Daily</title><link>https://finance.dpfeed.com/tags/kpti/</link><description>Recent content in Kpti on Finance Insights Daily</description><image><title>Finance Insights Daily</title><url>https://finance.dpfeed.com/images/finance-insights-og.jpg</url><link>https://finance.dpfeed.com/images/finance-insights-og.jpg</link></image><generator>Hugo -- 0.147.7</generator><language>en-us</language><lastBuildDate>Wed, 25 Mar 2026 06:13:48 +0000</lastBuildDate><atom:link href="https://finance.dpfeed.com/tags/kpti/index.xml" rel="self" type="application/rss+xml"/><item><title>Karyopharm's SENTRY Trial: Myelofibrosis Breakthrough Unveiled</title><link>https://finance.dpfeed.com/posts/karyopharm-s-sentry-trial-myelofibrosis-breakthrough-unveiled/</link><pubDate>Wed, 25 Mar 2026 06:13:48 +0000</pubDate><guid>https://finance.dpfeed.com/posts/karyopharm-s-sentry-trial-myelofibrosis-breakthrough-unveiled/</guid><description>Financial analysis and investment insights on Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis - Slid</description></item></channel></rss>